Insider · CIK 0001722733
David Pacitti
directorceoofficer
Files at AVNS (AVANOS MEDICAL, INC.), OBIO (Orchestra BioMed Holdings, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +101,341 | $0.00 | $0 | 343,388 | Mar 17, 2026 |
| Mar 13, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +239,354 | $0.00 | $0 | 239,354 | Mar 17, 2026 |
| Aug 7, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +15,000 | $0.00 | $0 | 44,968 | Aug 8, 2025 |
| Jun 24, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +12,422 | $0.00 | $0 | 29,968 | Jun 26, 2025 |
| Jun 24, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +36,797 | $0.00 | $0 | 36,797 | Jun 26, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.